Amundi Index Solutions - Amundi Index MSCI Europe AE-CRegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.1 | 17.5 | -4.2 | 13.2 | 9.2 | |
+/-Cat | -2.2 | 2.1 | 4.1 | 1.6 | 1.7 | |
+/-B’mrk | -0.4 | -0.2 | 0.3 | 0.0 | -0.1 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 25/09/2024 | EUR 287.75 | |
Day Change | 0.20% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU0389811885 | |
Fund Size (Mil) 25/09/2024 | EUR 4374.69 | |
Share Class Size (Mil) 24/09/2024 | EUR 120.70 | |
Max Initial Charge | 4.50% | |
Ongoing Charge 22/06/2024 | 0.30% |
Investment Objective: Amundi Index Solutions - Amundi Index MSCI Europe AE-C |
To track the performance of MSCI Europe Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Isabelle Lafargue 07/09/2015 | ||
Inception Date 25/09/2008 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index MSCI Europe AE-C | 23/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 3.55 |
ASML Holding NV | Technology | 2.84 |
Nestle SA | Consumer Defensive | 2.27 |
SAP SE | Technology | 2.14 |
AstraZeneca PLC | Healthcare | 2.13 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index MSCI Europe AE-C |